Skip to main content
Douglas Galasko, MD, Neurology, La Jolla, CA

DouglasRGalaskoMD

Neurology • La Jolla, CA

Professor, Neurosciences, UCSD School of Medicine Director of the UCSD Shiley-Marcos Alzheimer's Disease Research Center (ADRC).

Join to view full profile

Dr. Galasko is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Galasko's full profile

Already have an account?

  • Office

    9350 Campus Point Dr
    Perlman Ambulatory Care Center - Neurology
    La Jolla, CA 92037
    Phone+1 858-657-8540
    Fax+1 858-657-8557

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 1984 - 1987
  • Boston University Medical Center
    Boston University Medical CenterInternship, Internal Medicine, 1983 - 1984
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2026
  • MD State Medical License
    MD State Medical License 1985 - 1988
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Comprehensive Screening of Copy Number Variability in Dementia with Lewy Bodies  
    Eliezer Masliah, Ted Dawson, Nigel J Cairns, John C Morris, Sonja W Scholz, John Q Trojanowski, Liana Rosenthal, Lawrence S Honig, Douglas Galasko, Thomas G Beach, Ron..., ScienceDirect
  • Microstructural Brain Changes Track Cognitive Decline in Mild Cognitive Impairment  
    James B Brewer, Christina E Wierenga, Douglas Galasko, ScienceDirect

Lectures

  • 14th International Conference on Alzheimer's Drug Discovery 
    Alzheimer's Drug Discovery Foundation, Jersey City, New Jersey - 9/9/2013

Press Mentions

  • New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in the Blood – Neuroscience News
    New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in the Blood – Neuroscience NewsDecember 29th, 2022
  • Test Detects Alzheimer’s Neurodegeneration in Blood
    Test Detects Alzheimer’s Neurodegeneration in BloodDecember 28th, 2022
  • New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in Blood
    New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in BloodDecember 27th, 2022
  • Join now to see all

Grant Support

  • Clinical Core BNational Institute On Aging2009–2012
  • Administrative Core ANational Institute On Aging2009–2012
  • Alzheimer'S Disease Research CenterNational Institute On Aging2007–2012
  • Clinical Studies Of Nsaidss As Y-Secretase Modulators In Alzheimer'S DiseaseNational Institute On Aging2009–2011
  • A Trial Of Ttp488 To Slow The Rate Of Clinical Progression Of Patients With ADNational Institute On Aging2006–2010
  • Testing The Role Of Axonal Transport Disturbance In AD?National Institute On Aging2007–2008
  • Biomarkers In Aging, MCI And Alzheimer'S DiseaseNational Institute On Aging2003–2007
  • Age Related Neurodegenerative Diseases In MicronesiaNational Institute On Aging2000–2006
  • Prevalence /Incidence /Risk Factors For Dementia On GuamNational Institute On Aging2002
  • Core--ClinicalNational Institute On Aging2002
  • Core---Administrative, Database, And StatisticalNational Institute On Aging2002
  • Clinical Evaluation Of Nsaids As Anti-Amyloid CompoundsNational Institute On Aging2002
  • A Phase 1B Study Of Ipa In ADNational Institute On Aging2001–2002

Dr. Douglas Galasko, Dr. Douglas Galasko, MD, Dr. D Galasko, Dr. Douglas R Galasko